Halaman 3 - Radioterapi Dokter Terbaik - TOP-99 dokter

Dr. Amir berspesialisasi dalam terapi kanker payudara tingkat lanjut, termasuk radioterapi. Penelitian dan perawatannya didukung oleh lebih dari 30 presentasi pada pertemuan-pertemuan ilmiah.

• Menerima Penghargaan Penelitian Translasi Kanker Payudara ESMO (ESMO Breast Cancer Translational Research Award)
• Mendapat pelatihan fellowship dalam penelitian kanker payudara di Emory University
• Anggota European Society of Medical Oncology (Perhimpunan Onkologi Medis Eropa)
• Penerima beberapa Penghargaan Best Paper of the Year ISCORT

Profesor Madya sejak 2016, Dr. Ozatli berspesialisasi dalam kanker payudara, paru-paru, dan gastrointestinal di Istinye University Liv Hospital Bahcesehir.

• Spesialis Penyakit Dalam dengan pengalaman di rumah sakit terkemuka di Turki
• Berpengalaman dalam menangani kasus onkologi kompleks pada berbagai jenis kanker
• Anggota asosiasi onkologi Turki dengan pencapaian akademis yang progresif

Dr. Auala Hubert memimpin Pusat Kanker Gastrointestinal di Hadassah Medical Center, dengan 33 tahun pengalaman khusus dalam onkologi dan radioterapi.

• Berspesialisasi dalam Onkologi Medis & Radioterapi
• Dokter senior di Rumah Sakit Universitas Hadassah
• Tersertifikasi dalam Onkologi & Radioterapi
• Anggota Perhimpunan Onkologi Klinis Israel

Dr. Alon Pikarsky memiliki lebih dari 30 tahun keahlian bedah, berspesialisasi dalam bedah kolorektal di Hadassah Medical Center.

• Instruktur Bedah sejak 1995, melatih calon ahli bedah
• Direktur Program Mahasiswa Kedokteran sejak 1997
• Bersertifikat Dewan Israel dalam Bedah Umum sejak 1998
• Anggota berbagai asosiasi bedah sejak 1998

Dr. Gal Goldstein, yang diakui dalam daftar dokter terbaik Forbes, memimpin Departemen Onkologi dan Hemato-Onkologi Pediatrik di Rumah Sakit Hadassah Ein Kerem.

• Lebih dari 20 tahun spesialisasi dalam hemato-onkologi pediatrik dan transplantasi sumsum tulang haploidentik
• Anggota dari berbagai asosiasi onkologi bergengsi termasuk SIOP dan ISPHO
• Fokus pada retinoblastoma dan pengobatan presisi dalam onkologi pediatrik

Dr. Alemdar berspesialisasi dalam onkologi medis dengan pelatihan ekstensif di Universitas Akdeniz, institusi terkemuka di Turki.

• Bersertifikat dewan dalam onkologi medis sejak 2018
• Lebih dari 15 tahun pengalaman dalam onkologi
• Bekerja di Kompleks Rumah Sakit Medical Park Antalya

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Dr. Eytan Aharon Ben‑Ami, MD, is a Senior Physician in the Sarcoma and Bone Oncology Service at Sheba Medical Center. He heads the Oncology Division and the Early-Phase Clinical Trials Unit. He founded the Sheba Clinical Research Organization. He is an academic affiliate at Tel Aviv University.

He specializes in sarcomas and primary bone tumors, including soft tissue sarcoma, liposarcoma, leiomyosarcoma, and osteosarcoma. He leads Phase I trials in targeted therapy and immunotherapy. He designs personalized treatment plans for rare cancers. He also develops patient-centered programs, including pilots in advanced immunotherapy delivery.

He completed a fellowship in Sarcoma and Bone Oncology at the Dana-Farber Cancer Institute/Harvard Cancer Center. He has authored more than 40 publications on early detection, molecular and viral mechanisms, and new cancer therapies.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Dr. Lucía González Cortijo is a medical oncologist with more than 20 years of experience. She has led the Medical Oncology Department at Hospital Universitario Quirónsalud Madrid since 2020. Her focus areas include breast and gynecologic cancers. She also works in precision oncology, targeted therapies, and immunotherapy.

She has been Principal Investigator in more than 20 Phase II–III clinical trials. She has also served as sub-investigator in over 50 international trials. She previously worked at Quirónsalud Madrid from 2009 to 2020. Before that, she was at MD Anderson Cancer Center Madrid from 2002 to 2009.

She holds an MD and a PhD (cum laude) from the Autonomous University of Madrid. She completed her Medical Oncology specialty training at Hospital 12 de Octubre. She also earned a Master’s in Molecular Oncology. She is a member of SEOM, ESMO, ASCO, and GEICAM. She is a university lecturer.

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Berspesialisasi dalam tumor kepala dan leher serta kanker tiroid dengan teknik radioterapi canggih di Pusat Medis Hadassah.

• Pelatihan dalam bedah radio (radiosurgery) di Memorial Sloan Kettering Cancer Center
• Lebih dari 20 tahun pengalaman dalam onkologi dan radioterapi
• Mantan Kepala Divisi Onkologi Kepala dan Leher di Pusat Kanker Davidoff
• Direktur Departemen Onkologi di Hadassah sejak 2019

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Berspesialisasi dalam bedah jantung berbantuan robot – pendekatan mutakhir dengan teknik yang presisi dan minimal invasif.

• Lebih dari 25 tahun pengalaman dalam bedah jantung
• Keahlian dalam perbaikan & penggantian katup jantung
• Pelatihan di University of California, San Diego
• Melakukan bedah jantung pediatrik

Kepala Onkologi Radiasi di Samsung Medical Center – Profesor Lim berspesialisasi dalam kasus kanker kompleks.

• Mendapat pelatihan di Fakultas Kedokteran Universitas Nasional Seoul (Seoul National University College of Medicine)
• Berspesialisasi dalam tumor lambung, pankreatobilier, dan tumor SSP
• Juga menangani tumor pediatrik dan sarkoma
• Menyelesaikan pelatihan spesialis di Samsung Medical Center dan Seoul National University Hospital